Health
First Generic Version of Twice-Yearly HIV Prevention Shot Clears FDA Review
Dr. Reddy's lenacapavir, aimed at 120 lower-income countries, is expected to cost about $40 a person per year.
Dr. Reddy's Laboratories News
All Happy News Company coverage of Dr. Reddy's Laboratories: the latest health news, with links to every original source.
Got good news? Let's share it.
Publish your impact story, donation, milestone or community launch on Happy News Company from $99. Nonprofits save 25%.